Glaucoma

Glaucoma appeared tied to significant costs not only for individuals, but also for society as a result of premature retirement and loss of productivity, according to a study conducted in Finland and published in PLOS One.

Timolol maleate 0.5% microdrops delivered with the Nanodropper Adaptor met three noninferiority endpoints in lowering IOP compared with conventional timolol drops, according to a study.

The “365 breathing” technique significantly increased parasympathetic activity and reduced IOP and serum cortisol levels after 6 weeks in patients with glaucoma, according to a study published in the Journal of Glaucoma.

With the continued increase in the older patient population and a nearly 20% decline in the health care workforce, there is an urgent need to expand ocular telehealth, according to a speaker at the American Glaucoma Society meeting.

When children and teens present with early onset of keratoconus, we often see severe disease and rapid progression.

In the dynamic landscape of diabetic macular edema management, the PALADIN study continues to offer helpful insights into the outcomes of IOP-lowering surgery after treatment with Iluvien.

FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Kevin L. Waltz, OD, MD, speaks about the ViaLase femtosecond laser technology for high-precision trabeculotomy.

Smartphones are nearly ubiquitous and powerful tools that allow physicians to take better care of patients and help patients improve care for themselves, according to a speaker at the American Glaucoma Society meeting.

Patients with advanced glaucoma should be offered trabeculectomy as their primary intervention, according to a study presented at the American Glaucoma Society meeting.

Glaucoma is a major blinding disease. The onset is hidden, and early diagnosis is difficult. Cost-effective screening tools are lacking, and often we diagnose the disease when the optic nerve damage is irreversible.